1. Archives
  2. Magazine - 09 Feb 2017

  3. Marlowe strikes a scorcher of a deal

Latest acquisition triggers major upgrade to earnings forecasts

|Feature|by Dan Coatsworth
< The true cost of investing in funds
Cello has US biotech opportunity in its sights >
Issue: 09 Feb 2017 - Page 39 |
Contents
Next:
Cello has US biotech opportunity in its sights
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account. AJ Bell logo
Dan Coatsworth profile pic
Dan Coatsworth

Issue Contents

-37%: Pebble Beach soaked by profit warning
54 oil rigs: biggest increase since 2014
70% of free cash flow: Centamin’s golden reward
333,233%: Anglo Pacific’s potential return on coal mining royalty
163%: Potential gain on our NetDimensions idea
Global economic growth at 22 month high
How to get first dibs on Woodford’s 5% income fund
FTSE 100: How much can you make on each stock this year?
Wizz Air still attractive despite setback
Cello has US biotech opportunity in its sights
Advanced Oncotherapy shock
Adept Telecom ups M&A ante
Marlowe strikes a scorcher of a deal
Autins CEO walks out six months after IPO
The impact of the pound on your portfolio

Most Read

Receive our
daily news email

Subscribe to the latest investing news by entering your email address below

You can opt out at any time.

For five days a week you will get

  • The latest company news
  • Insight into investment trends
  • Round-up of directors' buys and sells
  • Articles from Shares magazine
Sharesmagazine cover

Plus more useful investment content and occasional promotional offers.

Shares Magazine Latest Issue Cover
Latest Issue:
01 May 2025

Market Overview

UK 350 Risers and Fallers

Issue Contents

-37%: Pebble Beach soaked by profit warning
54 oil rigs: biggest increase since 2014
70% of free cash flow: Centamin’s golden reward
333,233%: Anglo Pacific’s potential return on coal mining royalty
163%: Potential gain on our NetDimensions idea
Global economic growth at 22 month high
How to get first dibs on Woodford’s 5% income fund
FTSE 100: How much can you make on each stock this year?
Wizz Air still attractive despite setback
Cello has US biotech opportunity in its sights
Advanced Oncotherapy shock
Adept Telecom ups M&A ante
Marlowe strikes a scorcher of a deal
Autins CEO walks out six months after IPO
The impact of the pound on your portfolio